Used as an intermediate in pharmaceutical synthesis, particularly in the development of bioactive molecules and drug candidates. Its structure supports the creation of selective receptor ligands due to the presence of a protected amine group and a conformationally restricted cyclohexyl ring. Commonly employed in the preparation of compounds targeting central nervous system disorders and metabolic diseases. The tert-butyl carbamate (Boc) group allows for easy protection and deprotection during multi-step synthesis, making it valuable in medicinal chemistry and process development.